Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof

A technology for non-steroidal anti-inflammatory drugs and compounds, which can be used in anti-inflammatory agents, anti-infective drugs, pharmaceutical formulations, etc., and can solve the problems of unstable room temperature storage, easy volatility, poor water solubility and low melting point.

Inactive Publication Date: 2011-06-01
SUZHOU UNIV
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the paeonol molecule contains phenolic hydroxyl groups, and has a low melting po

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof
  • Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof
  • Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0023] Example 1: Synthesis of 5-methoxy-2-acetylphenyl ibuprofen axetil (AXC 1 )

[0024] In a 25 mL three-necked flask, add ibuprofen (1.03 g, 5.0 mmol) and thionyl chloride (1.5 mL, 20.0 mmol), reflux for 2 h, and evaporate the thionyl chloride under reduced pressure. The residue was dissolved in 10 mL of anhydrous dichloromethane, cooled to 0°C in an ice bath, paeonol (0.83 g, 5.0 mmol) and pyridine (0.8 mL, 10.0 mmol) were added, stirred for 2 h under an ice bath, and then 10 mL of water was added , extracted with dichloromethane (10 mL×3), combined the organic phases, successively washed with saturated NaHCO 3 solution, distilled water and saturated brine solution, anhydrous MgSO 4 dry. Filtration, the filtrate was concentrated, and column chromatography was carried out, the eluent was petroleum ether:ethyl acetate (v:v)=6:1. The eluates were combined, the solvent was evaporated, and the oil was pumped to dryness to obtain a pale yellow solid, yield 77.2%, mp 32.0-33...

Example Embodiment

[0025] Example 2: Synthesis of 5-methoxy-2-acetyl phenylketoprofen axetil (AXC 2 )

[0026] In a 25 ml round-bottomed flask, ketoprofen (1.0 g, 4.0 mmol), thionyl chloride (1.2 mL, 16.0 mmol), and 1.0 mL of pyridine were added, and the mixture was refluxed for 1 h. The excess thionyl chloride was evaporated under reduced pressure, the residue was dissolved in 10 mL of anhydrous dichloromethane, cooled in an ice bath, paeonol (0.60 g, 3.0 mmol) and triethylamine (1.4 mL, 10.0 ml) were added, Stir at room temperature for 3h. Add 0.5N sodium hydroxide solution, continue stirring for 20min, extract with dichloromethane (15mL×3), combine the organic phases, anhydrous MgSO 4 dry. Filtration, the filtrate was concentrated, and column chromatography was carried out, the eluent was petroleum ether:ethyl acetate (v:v)=9:1. The eluates were combined and the solvent was evaporated to give an oil in 68.2% yield. IR(cm -1 , KBr): 1759.2 (C=O), 1643.5 (C=O); 1 HNMR (400MHz, CDCl 3 , ...

Example Embodiment

[0027] Example 3: 3-hydroxy-4-acetylphenyl ibuprofen axetil (AXC 3 )

[0028] In a 25mL round-bottom flask, 2,4-dihydroxyacetophenone (0.76g, 5.0mmol) was dissolved in 8mL of anhydrous dichloromethane, and then ibuprofen (1.03g, 5.0mmol), DCC (1.03g) were added. , 5.0 mmol) and DMAP pellets were stirred until dissolved. After 2 hours, filter, concentrate the filtrate, and perform column chromatography. The eluent is petroleum ether:ethyl acetate (v:v)=9:1. The eluents are combined, the solvent is evaporated, and the oil is pumped to dryness to obtain an oily substance, Yield 71.25%. IR(cm -1 , KBr): 3500~3100(OH), 1766.9(C=O), 1643.5(C=O); 1 HNMR (400MHz, CDCl 3 , TMS), δ: 0.80 (d, 6H, CH 3 ), 1.60(d, 3H, CH 3 ), 1.90 (m, 1H, CH), 2.55 (d, 2H, CH) 2 ), 2.72(s, 3H, CH 3 ), 3.80(m, 1H, CH), 6.59(m, 2H, ArH), 7.16(d, 2H, J=7.2Hz, ArH), 7.27(d, 2H, J=7.6Hz, ArH), 7.80( d, 1H, J=8.0 Hz, ArH), 12.40 (s, 1H, OH); HR-MS: m / z Calcd for C 21 H 24 O 4 340.1675, Found: 340.16...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound obtained by esterifying carboxylic acid-containing nonsteroidal anti-inflammatory drugs with paeonol and nor-paeonol, a preparation method and application thereof. The compound is obtained by taking the carboxylic acid-containing nonsteroidal anti-inflammatory drugs such as ibuprofen and the like as a raw material and esterifying the raw material with the paeonol through sulfonyl chlorination or with the nor-paeonol by a carbimide method. The compound has anti-inflammatory, and antipyretic and analgesic effects.

Description

technical field [0001] The invention relates to a class of ester-forming compounds containing carboxylic acid non-steroidal anti-inflammatory drugs, paeonol and norpaeonol and a preparation method thereof. The present invention also relates to pharmaceutical compositions containing these compounds with antipyretic, analgesic and anti-inflammatory effects. Background technique [0002] Inflammation is an extremely complex pathophysiological process mediated by various inflammatory mediators. Nonsteroidal anti-inflammatory drugs (NSAIDs) can inhibit prostaglandins (PGs), leukotrienes (LTs) and other inflammatory mediators, have excellent anti-inflammatory, analgesic and antipyretic effects, and their clinical application is extremely Widely used: It is widely used in rheumatoid arthritis, osteoarthritis and other rheumatic diseases; it can also be used for pain caused by trauma, toothache and tumor; it can also be used for reducing fever; small doses of aspirin can also resis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C69/612C07C69/738C07C229/42C07C69/84C07D209/28C07C317/44C07D207/337C07D491/052C07C69/65C07C69/736C07C69/734C07D333/24C07D207/20C07D209/46C07C229/58C07D213/80C07C67/14C07C67/08C07C227/18C07C315/04C07D213/803A61K31/216A61K31/618A61K31/405A61K31/40A61K31/407A61K31/381A61K31/402A61K31/4035A61K31/24A61K31/455A61P29/00A61P19/02A61P19/04A61P31/00
Inventor 敖桂珍崔京浩
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products